Psilocybin for the treatment of Alzheimer’s disease
Frontiers in Neuroscience July 10, 2024 Siyi Zheng, Rong Ma, Yang Yang et al. 23 citations
Alzheimer’s disease (AD) stands as a formidable neurodegenerative ailment and a prominent contributor to dementia. The scarcity of available therapies for AD accentuates the exigency for innovative treatment modalities. Psilocybin, a psychoactive alkaloid intrinsic to hallucinogenic mushrooms, has garnered attention within the neuropsychiatric realm due to its established safety and efficacy in...
DOI: 10.3389/fnins.2024.1420601 (opens in new tab)
Psilocybin
Disease
Hallucinogen